New stent aims to tackle multiple blocked arteries in one go
NCT ID NCT06663696
First seen May 02, 2026
Summary
This study is testing a special stent called Supraflex Cruz in 1000 people who have blockages in more than one heart artery. The stent is coated with a drug (sirolimus) that slowly releases to help keep the artery open, and the coating dissolves over time. Researchers want to see if it is safe and works well in real-world patients who need multiple stents.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIVESSEL CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Habib Thameur Hospital
RECRUITINGTunis, 1089, Tunisia
Contact
-
Sahloul Hospital
RECRUITINGSousse, 4054, Tunisia
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
sirolimus-eluting stent
What this could lead to
If successful, this stent could provide a safe and effective way to treat multiple blocked arteries in one procedure, reducing the need for repeat surgeries.
What could go wrong
This is a registry study, not a randomized trial, so results may be less definitive. Stents carry risks like blood clots or re-narrowing, and long-term outcomes are still being tracked.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.